Search

Your search keyword '"Inghilleri, M."' showing total 663 results

Search Constraints

Start Over You searched for: Author "Inghilleri, M." Remove constraint Author: "Inghilleri, M."
663 results on '"Inghilleri, M."'

Search Results

1. Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants

2. Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy

4. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

5. Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: KENNEDY’S DISEASE AND MYELODISPLASTIC SYNDROME: A POSSIBLE NEW ENTITY IN MYELOID NEOPLASM GERMLINE PREDISPOSITION. A CASE REPORT

6. Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies

9. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

10. Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients

13. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (vol 53, pg 1636, 2021)

14. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

16. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

17. Consistent improvement with eculizumab across muscle groups in myasthenia gravis

20. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab:subgroup analysis of REGAIN and its extension study

21. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

22. A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients

25. Eculizumab Improves Fatigue in Refractory Generalized Myasthenia Gravis

29. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

44. A case of motor neuron involvement in Gaucher disease

47. Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)

48. Malattia del motoneurone

Catalog

Books, media, physical & digital resources